Dimensional Fund Advisors LP Has $39.17 Million Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Dimensional Fund Advisors LP increased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 2.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 423,846 shares of the company's stock after buying an additional 10,462 shares during the period. Dimensional Fund Advisors LP owned 2.81% of U.S. Physical Therapy worth $39,173,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of USPH. Conestoga Capital Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 1.0% during the first quarter. Conestoga Capital Advisors LLC now owns 15,075 shares of the company's stock worth $1,702,000 after buying an additional 145 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in U.S. Physical Therapy by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company's stock valued at $1,480,000 after purchasing an additional 170 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company's stock valued at $110,000 after purchasing an additional 186 shares during the period. Louisiana State Employees Retirement System grew its position in U.S. Physical Therapy by 2.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company's stock worth $702,000 after purchasing an additional 200 shares during the last quarter. Finally, ProShare Advisors LLC increased its holdings in shares of U.S. Physical Therapy by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 3,002 shares of the company's stock worth $339,000 after purchasing an additional 206 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Barrington Research reissued an "outperform" rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Friday, September 20th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company's stock, valued at approximately $580,635. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now owns 18,904 shares of the company's stock, valued at $1,627,445.36. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Price Performance

USPH stock traded down $1.64 during trading on Tuesday, hitting $82.99. The company had a trading volume of 85,441 shares, compared to its average volume of 87,855. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. The company has a fifty day moving average price of $87.16 and a two-hundred day moving average price of $96.04. U.S. Physical Therapy, Inc. has a fifty-two week low of $78.08 and a fifty-two week high of $113.63. The company has a market cap of $1.25 billion, a P/E ratio of 67.47, a P/E/G ratio of 4.13 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.76 EPS. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.51 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.12%. U.S. Physical Therapy's payout ratio is 143.09%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.